Regenerative cartilage therapy targets EU launch

co.don AG currently markets its regenerative therapy methods in Germany, where uptake is increasing among orthopedic surgeons, trauma surgeons and neurosurgeons.

Like 1 Comment
Page of
Go to the profile of co.don


co.don AG, a fully integrated biopharmaceutical company, is a leading specialist in autologous cell cultivation (i.e., using the patient’s own cells) for the regenerative treatment of articular cartilage defects and spinal disc defects.

No comments yet.